These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 7913793)
21. Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy. Rättyä J; Turkka J; Pakarinen AJ; Knip M; Kotila MA; Lukkarinen O; Myllylä VV; Isojärvi JI Neurology; 2001 Jan; 56(1):31-6. PubMed ID: 11148232 [TBL] [Abstract][Full Text] [Related]
22. Valproate metabolites in high-dose valproate plus phenytoin therapy. Sugimoto T; Muro H; Woo M; Nishida N; Murakami K Epilepsia; 1996 Dec; 37(12):1200-3. PubMed ID: 8956852 [TBL] [Abstract][Full Text] [Related]
23. Standard approach to antiepileptic drug treatment in the United States. Pellock JM Epilepsia; 1994; 35 Suppl 4():S11-8. PubMed ID: 8174515 [TBL] [Abstract][Full Text] [Related]
24. The effect of chronic carbamazepine, valproic acid and phenytoin medication on the periodontal condition of epileptic children and adolescents. Galas-Zgorzalewicz B; Borysewicz-Lewicka M; Zgorzalewicz M; Borowicz-Andrzejewska E Funct Neurol; 1996; 11(4):187-93. PubMed ID: 8934150 [TBL] [Abstract][Full Text] [Related]
25. Activity of gamma-glutamyl transpeptidase in serum of patients receiving anticonvulsant of anticoagulant therapy. Acheampong-Mensah D Clin Biochem; 1976 Apr; 9(2):67-70. PubMed ID: 4235 [TBL] [Abstract][Full Text] [Related]
26. Clinical validation and implications of dried blood spot sampling of carbamazepine, valproic acid and phenytoin in patients with epilepsy. Kong ST; Lim SH; Lee WB; Kumar PK; Wang HY; Ng YL; Wong PS; Ho PC PLoS One; 2014; 9(9):e108190. PubMed ID: 25255292 [TBL] [Abstract][Full Text] [Related]
27. A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. The Italian TDM Study Group in Epilepsy. Jannuzzi G; Cian P; Fattore C; Gatti G; Bartoli A; Monaco F; Perucca E Epilepsia; 2000 Feb; 41(2):222-30. PubMed ID: 10691121 [TBL] [Abstract][Full Text] [Related]
28. Effects of Sodium Valproate Monotherapy on Blood Liver Enzyme Levels in Patients with Epilepsy: A Meta-Analysis. Fu J; Tao T; Li Z; Chen Y; Chen X; Li J; Peng L Horm Metab Res; 2021 Jul; 53(7):425-434. PubMed ID: 34282594 [TBL] [Abstract][Full Text] [Related]
29. [Rise in gamma-GT during anticonvulsive therapy]. Deisenhammer E; Schwarzbach H; Sommer R Wien Klin Wochenschr; 1982 Nov; 94(21):584-5. PubMed ID: 6132495 [TBL] [Abstract][Full Text] [Related]
30. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy. Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491 [TBL] [Abstract][Full Text] [Related]
31. Cognitive function in adult epileptic patients established on anticonvulsant monotherapy. Gillham RA; Williams N; Wiedmann KD; Butler E; Larkin JG; Brodie MJ Epilepsy Res; 1990 Dec; 7(3):219-25. PubMed ID: 2289480 [TBL] [Abstract][Full Text] [Related]
32. Total cholesterol, high-density lipoprotein cholesterol, and triglycerides in children receiving antiepileptic drugs. Franzoni E; Govoni M; D'Addato S; Gualandi S; Sangiorgi Z; Descovich GC; Salvioli GP Epilepsia; 1992; 33(5):932-5. PubMed ID: 1396438 [TBL] [Abstract][Full Text] [Related]
33. Discontinuation of phenytoin, carbamazepine, and valproate in patients with active epilepsy. Duncan JS; Shorvon SD; Trimble MR Epilepsia; 1990; 31(3):324-33. PubMed ID: 2111768 [TBL] [Abstract][Full Text] [Related]
34. Liver function tests in persons receiving anticonvulsant medications. Wall M; Baird-Lambert J; Buchanan N; Farrell G Seizure; 1992 Sep; 1(3):187-90. PubMed ID: 1344766 [TBL] [Abstract][Full Text] [Related]
35. Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy. Voudris KA; Attilakos A; Katsarou E; Drakatos A; Dimou S; Mastroyianni S; Skardoutsou A; Prassouli A; Garoufi A Epilepsy Res; 2006 Aug; 70(2-3):211-7. PubMed ID: 16781120 [TBL] [Abstract][Full Text] [Related]
36. Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients. Goto S; Seo T; Hagiwara T; Ueda K; Yamauchi T; Nagata S; Ando Y; Ishitsu T; Nakagawa K J Pharm Pharmacol; 2008 Feb; 60(2):267-72. PubMed ID: 18237476 [TBL] [Abstract][Full Text] [Related]
37. Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. de Silva M; MacArdle B; McGowan M; Hughes E; Stewart J; Neville BG; Johnson AL; Reynolds EH Lancet; 1996 Mar; 347(9003):709-13. PubMed ID: 8601999 [TBL] [Abstract][Full Text] [Related]
38. Prediction of free levels of phenytoin and carbamazepine in patients comedicated with valproic acid. Ratnaraj N; Hjelm M Ther Drug Monit; 1995 Aug; 17(4):327-32. PubMed ID: 7482684 [TBL] [Abstract][Full Text] [Related]
39. Noninvasive screening for preclinical atherosclerosis in children on phenytoin or carbamazepine monotherapy: a cross sectional study. Sankhyan N; Gulati S; Hari S; Kabra M; Ramakrishnan L; Kalra V Epilepsy Res; 2013 Nov; 107(1-2):121-6. PubMed ID: 24050974 [TBL] [Abstract][Full Text] [Related]
40. [Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or phenytoin]. Pita-Calandre E; Rodríguez-López CM; Cano MD; Peña-Bernal M Rev Neurol; 1998 Nov; 27(159):785-9. PubMed ID: 9859151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]